Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific

Clinical trial NCT02442349 · COMPLETED

Trial details

NCT number: NCT02442349
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2015-06-22
Primary completion: 2016-03-04
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.